Uncovers cavitation effects of engineered protein nanoparticles using ultrasound, suggesting their potential as sonosensitizers.
(optical density at 600 nm) = 1.0 was identified for robust cavitation activity. These findings lay the groundwork for optimizing GVs-E.coli-mediated ultrasound therapies and accelerate their clinical translation as next-generation sonosensitizers.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: